Dataset opportunity
Vitestro — Medical Imaging Dataset Opportunity
Moderate medical imaging dataset held by Vitestro, usable for Diagnostic AI and Computer Vision.
Score
68.6
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
Data Sharing Agreement
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global AI in Medical Diagnostics Market = $1.1 Billion in 2023, CAGR 25.2%.
Recent dated external facts that triggered this opportunity — auditable provenance.
- 📰press2026-09-01
How Vitestro’s first-of-its-kind Aletta robot autonomously draws blood
medicaldesignandoutsourcing.com ↗
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Profile
Dataset profile
Type
Medical Imaging Dataset
Modality
Image
Sector
healthcare
Volume
Moderate
Freshness
Real-time
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Owned by the company — GDPR-sensitive (PII review)
Buyer persona
Medical-AI & diagnostic-imaging companies
Vitestro provides a highly specialized Medical Imaging Dataset for Diagnostic AI development, sourced from its proprietary autonomous blood-drawing device. The collection features coupled ultrasound and infrared images of patient vasculature, enriched with associated `iot_data` from the device and `medical_records`. This multi-modal dataset is exceptionally suited for training and validating algorithms for complex tasks like real-time vein detection and cannulation guidance, offering a significant advantage in the automated medical procedures space.
The business value is anchored in the rapidly expanding AI in Medical Diagnostics market, which was valued at $1.1 Billion in 2023 and is projected to grow at a CAGR of 25.2%. Despite access complexities due to strict GDPR and EU MDR compliance, alongside shared data ownership with hospital partners, the proprietary and rare nature of this hardware-linked imaging data makes it a crucial asset for any entity aiming to innovate and capture share in this high-growth market. ⚠ Diligence (valuable data, access to negotiate): Medical data subject to strict GDPR and EU Medical Device Regulation (MDR) compliance; Data ownership may involve hospital partners where devices are deployed; Highly specialized ultrasound and infrared imaging datasets linked to proprietary hardware · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence collectively proves Vitestro holds a large-scale, proprietary dataset from the A.D.A.P.T. clinical study, the largest of its kind for autonomous blood drawing. The data combines AI-driven ultrasound and infrared vein imagery with performance logs from over 1,500 patients, creating a unique asset for diagnostic AI developers. In a global AI medical diagnostics market projected to grow at over 25% annually, this dataset is critical for training and validating next-generation procedural guidance and diagnostic imaging algorithms.
See dimension details ↓- Dataset Specificity90
dominant 'medical_records', sector healthcare, 3 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity82
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
real-time/streaming
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value84
fit for Diagnostic AI
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand90
AI buyer demand is extremely high, driven by the rapid growth of the AI in Medical Diagnostics market, which is expanding at a CAGR of 25.2%.
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
PII/regulated
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
medium difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 evidence types, 3 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License62
ownership=company_owned, licensing=gdpr_sensitive
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation22
0 data-appetite signals (0 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high, 1 recent external signals — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit100
✓ good target — Vitestro is an ideal target as it develops and sells a physical robotic device for blood collection, generating proprietary ultrasound and near-infrared imaging data as a by-product of its core operational business.
- Deep Qualification90
⚠ needs review — Vitestro is a tooling vendor selling the Aletta® robotic phlebotomy device; the valuable imaging data is a byproduct generated and owned by its hospital customers under strict medical regulations, making direct data acquisition from Vitestro unfeasible. [data is owned by the company's customers; licensing restricted]
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Image collection
The dataset includes a unique collection of AI-driven 3D vein visualizations, combining both ultrasound and infrared imagery, which is highly sought after for developing advanced procedural guidance systems.
IoT / sensor data
The holder possesses detailed time-series performance logs from clinical trials, documenting needle trajectory and puncture precision to validate the 94.5% first-stick success rate of an autonomous system.
Medical records / imaging
This dataset is anchored by data from the A.D.A.P.T. study, the largest clinical trial for autonomous blood drawing, providing a robust foundation of over 1,500 patient encounters for model training and validation.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Vitestro Medical Imaging — a Moderate medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global AI in Medical Diagnostics Market = $1.1 Billion in 2023, CAGR 25.2% (source: Market.us). Investment score 68.6/100 (confidence 0.49). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Eumediq — Opportunité de jeu de données d'imagerie médicale
View opportunity →santéAcusurgical — Opportunité de jeu de données d'imagerie médicale
View opportunity →santéArtoptical — Opportunité de jeu de données d'imagerie médicale
View opportunity →Data Academy
Learn before you deal
- Combien vaut un dataset ?3 min read
- Comment se déroule une transaction de données3 min read
- Ce que vous avez le droit de vendre3 min read
News & Insights
Latest from the briefing
- Coûts opérationnels de la non-conformité aux lois sur les courtiers en données
- Comment se conformer aux demandes de suppression universelle de données en un clic
- Comment se conformer aux exigences de transparence des données du règlement européen sur l'IA